CAPTRUST Financial Advisors
KIN

CAPTRUST Financial Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-643
Closed -$6K – 4906
2021
Q2 		$6K Hold
643
– – ﹤0.01% 3825
2021
Q1 		$3K Buy
+643
New +$3.1K ﹤0.01% 3967

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

CAPTRUST Financial Advisors's KIN Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 643 shares — an estimated $6K sold.

CAPTRUST Financial Advisors first reported a position in KIN in Q1 2021 and held it in 2 quarters. The position peaked at $6K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 643 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $6K.
  • CAPTRUST Financial Advisors first reported a position in Kindred Biosciences, Inc. in Q1 2021 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Kindred Biosciences, Inc. position peaked at $6K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.